TB Alliance is governed by a Board of Directors, representing global perspectives and expertise in diverse areas of interest that ensure the success and sustainability of the organization.

Dr. Bruce Carter Chair Retired, Former CEO at Zymogenetics
Dr. Eric Goosby Professor of Medicine & Director of Global Health Delivery and Diplomacy
Ms. Jane Griffiths Retired, Former Global Head of Actelion
Mr. Sundar Kodiyalam Co-founder, Vatera Healthcare Partners
Ms. Nancy Miller-Rich Miller-Rich Associates
Mr. David Norton Retired, Former Company Group Chairman, Global Pharmaceuticals, Johnson & Johnson
Dr. Ariel Pablos-Méndez Professor of Medicine, Columbia University Medical Center
Dr. Mario Raviglione Vice-Chair Professor of Global Health at the University of Milan, Italy & Former Director of the Global Tuberculosis Programme at the World Health Organization (WHO)
Ms. Sangita Reddy Joint Managing Director, Apollo Hospitals Enterprise Limited
Ms. Shalini Sharp Strategic Advisor to Ultragenyx
Dr. Melvin Spigelman President & Chief Executive Officer, TB Alliance
Mr. Mitchell Warren Executive Director, AVAC

Our Pipeline

TB Alliance manages the largest pipeline of new TB drugs in history.

View the portfolio